Latest news
Loading news…
TNAX Biopharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Tokyo, Japan Founded 2018 101-250 employees For Profit
TNAX Biopharma is a biopharmaceutical company that offers the development and commercialization of novel antibody therapeutics drugs.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 19
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Organic Chemistry
Company Info
- Founded
- 2018
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 1
- HQ
- Tokyo, Japan
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0.1
- Trend (30d)
- 0
- Trend (90d)
- -0.1
Key People at TNAX Biopharma
CEO & Co-founder
Chief Scientific Officer & Co-founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to TNAX Biopharma
Loading news…
FAQs about TNAX Biopharma
People who checked this page also checked these
Browse the full Acquirezy directory.